Cardiorentis Competitors and Similar CompaniesClear all
Travere Therapeutics's competitors and similar companies include Immunicum.
 Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. | |
Founding Date | Founding Date 2011 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Dublin, IE | Locations Stockholm, SE HQ Leiden, NL |
Employees | Employees 46293% increase | Employees 28 |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 49.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $10.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $480.4m (FY, 2025) | Gross profit kr7.8m (FY, 2025) |
Net income | Net income ($25.5m) (FY, 2025) | Net income (kr113.3m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Immunicum
HQ
Stockholm, SE
Employees
28
Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
View company